SCHEMBL9746246

SCHEMBL9746246

CCCCOC(=O)C(N)/C=C/CP(=O)(O)O

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
ATM Q13315 1/20 0.40
ALDH1A1 P00352 2/20 0.38
LAP3 P28838 2/20 0.38
HPGD P15428 1/20 0.38
TSHR P16473 1/20 0.38
HCAR2 Q8TDS4 1/20 0.36
P2RY10 O00398 4/20 0.36
GPR34 Q9UPC5 1/20 0.36
S1PR2 O95136 1/20 0.35
S1PR4 O95977 1/20 0.35
S1PR1 P21453 1/20 0.35
TSPO P30536 1/20 0.35
TMEM97 Q5BJF2 1/20 0.35
S1PR3 Q99500 1/20 0.35
SIGMAR1 Q99720 1/20 0.35
S1PR5 Q9H228 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9746256 1.00 CYP2D6 (0.40) CYP2D6CYP2C9CYP2C19ATMALDH1A1
SCHEMBL9743034 0.95 LAP3 (0.40) CYP2D6CYP2C9CYP2C19LAP3P2RY10
SCHEMBL9743040 0.95 LAP3 (0.40) CYP2D6CYP2C9CYP2C19LAP3P2RY10
SCHEMBL9742668 0.94 LAP3 (0.41) ALDH1A1LAP3P2RY10GPR34S1PR2
SCHEMBL9745371 0.94 LAP3 (0.41) ALDH1A1LAP3P2RY10GPR34S1PR2
SCHEMBL9745364 0.94 LAP3 (0.41) ALDH1A1LAP3P2RY10GPR34S1PR2
SCHEMBL9742659 0.94 LAP3 (0.41) ALDH1A1LAP3P2RY10GPR34S1PR2
SCHEMBL9744696 0.91 CYP2D6 (0.42) CYP2D6CYP2C9CYP2C19ALDH1A1LAP3
SCHEMBL9744681 0.91 CYP2D6 (0.42) CYP2D6CYP2C9CYP2C19ALDH1A1LAP3
SCHEMBL9744820 0.84 CYP2D6 (0.55) CYP2D6CYP2C9CYP2C19ALDH1A1LAP3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5175344-A Anticonvulsants, anxiolytic agents CIBA-GEIGY CORPORATION (US) 1992-12-29 US disclosed
EP-0233154-B1 UNSATURATED AMINO-ACIDS CIBA-GEIGY AG (CH) 1991-12-18 EP disclosed
US-5051413-A For treatment of ischemia, antispasmodic agents, anticonvulsants and anxiety or manic conditions CIBA-GEIGY CORPORATION (US) 1991-09-24 US disclosed
EP-0302826-A2 Process for the preparation of unsaturated amino acid compounds CIBA-GEIGY AG (CH) 1989-02-08 EP disclosed
EP-0233154-A2 Unsaturated amino-acids CIBA-GEIGY AG (CH) 1987-08-19 EP disclosed